HOME >> MEDICINE >> NEWS
New evidence about positive three-tier co-pay performance presented at Express Scripts 2000 Outcomes Conference

Researcher first to study and report on prescription drug benefit tool

ST. LOUIS, June 28, 2000 -- Researcher Brenda Motheral, PhD, told participants of the fourth annual Express Scripts (NASD: ESRX) Outcomes Conference, held in St. Louis, that recent data indicates three-tier co-pay prescription programs have enjoyed a great deal of success since their inception two years ago.

Motheral, the author of numerous articles in the area of outcomes research, claims database methodology and managed care, conducted the first study within the healthcare industry that documents how implementation of a three-tier prescription co-pay plan affects pharmaceutical and medical utilization and expenditures, continuation with chronic medications and the percent of enrollees affected.

She told conference participants that the relatively new co-pay structure can significantly lower payers' trend in pharmaceutical expenditures, and members are not showing evidence of medication noncompliance, as was expected by some industry experts when the three-tier medication co-pay structure was initiated three years ago.

Motheral and co-investigator, Kathi Fairman, studied two comparable preferred provider organization (PPO) groups located in the same state. The plans had nearly identical demographic profiles in terms of age, gender and incidence of chronic illness.

Group one instituted a three-tier co-pay plan in 1998, changing from a two-tier plan with a $7/$12 co-pay structure to a co-pay structure of $8/$15/$25, depending on the tier level. For the year preceding implementation, drugs that were placed on tier three (brand name/non-formulary) constituted 14 percent of prescription claims.

Group two, the control group, maintained its $7/$12 two-tier structure for the duration of the study.

The study substantiated the claim that a three-tier structure can significantly lower plan sponsors' trend in pharmaceu
'"/>

Contact: Ryan Soderstrom
rsoderst@express-scripts.com
612-837-5160
Kupper Parker Communications
27-Jun-2000


Page: 1 2 3 4 5

Related medicine news :

1. More evidence of cannabis-induced psychosis
2. Not enough evidence that multivitamins prevent infections in the elderly
3. Emotional memory study reveals evidence for a self-reinforcing loop
4. Influenza vaccination programmes for children in USA and Canada based on little evidence
5. Scientific evidence for diets: dont believe everything you read
6. New evidence of retroviral involvement in amyotrophic lateral sclerosis
7. Two studies find evidence that sunlight may have beneficial influence on cancer
8. Study finds no evidence of a cancer personality
9. Penn researchers add more evidence to demonstrate role of COX inhibitors in heart-disease risk
10. USC researchers find evidence that progesterone signaling influences ovarian cancer risk
11. Chamomile tea: New evidence supports health benefits

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... , ... December 08, 2016 , ... ... offering Medication Therapy Management (MTM), adherence, and other pharmacist-delivered patient care services, has ... general counsel and Eric Hoessel to vice president of sales. , Litsinger ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... With the ... created the “What’s In Your Mouth?” (WIYM) campaign to inform dentists and patients about ... Dentistry, the dental implant and prosthetic market in the U.S. is projected to reach ...
(Date:12/8/2016)... , ... December 08, 2016 , ... Premier Fitness Camp ... FIT , the ultimate weight loss and wellness program, at their world headquarters of ... to provide immediate and long-term results to anyone seeking weight loss, personal development, a ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... development continuity to its innovative Unified Instance Manager architecture, meeting the needs ... this new version optimizes the unattended auto-dialing system without agents, Presence Robodialer, ...
(Date:12/8/2016)... ... 08, 2016 , ... STATEN ISLAND, N.Y., Nov. 24, 2016 ... the highest standards of trauma, maternity, cancer and chronic obstructive pulmonary disease (COPD) ... Dr. Daniel Messina. , Among the recognitions, the American College of Surgeons' (ACS) ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)...  Axovant Sciences Ltd. (NYSE: AXON ... the treatment of dementia, today announced a new ... trial evaluating treatment with intepirdine (RVT-101), combined with ... placebo in people with mild-to-moderate Alzheimer,s disease. This ... treatment was associated with reduced progression in dependence ...
(Date:12/8/2016)... Calif. , Dec. 8, 2016 IRIDEX Corporation ... to offer newly issued shares of common stock, $0.01 par ... to an underwritten public offering.  The final terms of the ... time of pricing, and there can be no assurance as ... IRIDEX expects to use the net proceeds it will ...
(Date:12/8/2016)... 8, 2016 Australia Glaucoma Surgery Devices ... new report, "Australia Glaucoma Surgery Devices Market Outlook ... Australia Glaucoma Surgery Devices market. The report provides ... units) and average prices (USD) within market segement ... provides company shares and distribution shares data for ...
Breaking Medicine Technology:
Cached News: